A better imaging agent for heart disease and breast cancer
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography (CT) scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use. The imaging agent is a tantalum oxide nanoparticle, which is inexpensive, and stays in the body long enough to image many different organs. The report appears in the Journal of the American Chemical Society.
Taeghwan Hyeon, Seung Hong Choi, and colleagues explain that CT is one of the most widely used medical ...








